Similar articles

• Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.

  Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H. Bechstein WO, et al. Transplant Proc. 1996 Apr;28(2):1008-10. Transplant Proc. 1996. PMID: 8623211 Clinical Trial. No abstract available.
• Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.

  Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO. Alloway RR, et al. Transplant Proc. 1996 Apr;28(2):995-7. Transplant Proc. 1996. PMID: 8623494 Clinical Trial. No abstract available.
• [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].

  Arnold JC, Theilmann L. Arnold JC, et al. Z Gastroenterol. 1995 Oct;33(10):624-5. Z Gastroenterol. 1995. PMID: 7502559 Clinical Trial. German. No abstract available.
• Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?

  Nashan B. Nashan B. Transplant Rev (Orlando). 2009 Jan;23(1):47-52. doi: 10.1016/j.trre.2008.08.005. Transplant Rev (Orlando). 2009. PMID: 19027616 Review.
• [Cyclosporin in transplantation management--especially after kidney transplantation].

  Quellhorst E. Quellhorst E. Internist (Berl). 1996 Jan;37(1):88-90. Internist (Berl). 1996. PMID: 8837834 Review. German. No abstract available.